Showing results (1-10 of 960) with videos related to

Sort By:
Pageof 96
Breast Cancer Research and Treatment|January 1, 1993
Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin CW Scheithauer, G Kornek, K Haider, et al.
Breast Cancer Research and Treatment|December 1, 1991
Phase II study of amonafide in advanced breast cancerW Scheithauer, C Dittrich, G Kornek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Amonafide as first-line chemotherapy for metastatic breast cancerG Kornek, M Raderer, D Depisch, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancerG Kornek, D Depisch, E M Temsch, et al.
Breast Cancer Research and Treatment|December 8, 2000
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factorW Kwasny, G Kornek, K Haider, et al.
Cancer|April 1, 1993
A phase I-II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomachG Kornek, F Schulz, D Depisch, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinomaW Scheithauer, G Kornek, H Rosen, et al.
Cancer|March 15, 1994
Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancerW Scheithauer, D Depisch, G Kornek, et al.
Oncology|January 1, 1989
Phase II evaluation of 5-fluorouracil, folinic acid and cisplatin in advanced-stage colorectal adenocarcinomaW Scheithauer, D Depisch, R Schiessel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
Pageof 96